[go: up one dir, main page]

WO2006104260A1 - Micromatrice d’acide nucleique, traitement pour sa production, et substrat pour une micromatrice d’acide nucleique - Google Patents

Micromatrice d’acide nucleique, traitement pour sa production, et substrat pour une micromatrice d’acide nucleique Download PDF

Info

Publication number
WO2006104260A1
WO2006104260A1 PCT/JP2006/307284 JP2006307284W WO2006104260A1 WO 2006104260 A1 WO2006104260 A1 WO 2006104260A1 JP 2006307284 W JP2006307284 W JP 2006307284W WO 2006104260 A1 WO2006104260 A1 WO 2006104260A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
substrate
microarray
acid microarray
filler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2006/307284
Other languages
English (en)
Japanese (ja)
Inventor
Noritsugu Umehara
Yoichi Akagami
Masaru Kato
Jun Imai
Hiroshi Yoshida
Nobutaka Kusaba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inc NATIONAL UNIVERSITY IWATE UNIVERSITY
Nagoya University NUC
Nipro Corp
Akita Prefecture
Inc National Univ Iwate University
Original Assignee
Inc NATIONAL UNIVERSITY IWATE UNIVERSITY
Nagoya University NUC
Nipro Corp
Akita Prefecture
Inc National Univ Iwate University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc NATIONAL UNIVERSITY IWATE UNIVERSITY, Nagoya University NUC, Nipro Corp, Akita Prefecture, Inc National Univ Iwate University filed Critical Inc NATIONAL UNIVERSITY IWATE UNIVERSITY
Priority to JP2007510586A priority Critical patent/JP5238250B2/ja
Publication of WO2006104260A1 publication Critical patent/WO2006104260A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00596—Solid-phase processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/00603—Making arrays on substantially continuous surfaces
    • B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
    • B01J2219/00608—DNA chips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00722—Nucleotides

Definitions

  • Nucleic acid microarray method for producing the same, and substrate for nucleic acid microarray
  • the present invention relates to a nucleic acid microarray, a method for producing the same, and a substrate for nucleic acid microarrays. More specifically, the present invention relates to a plastic nucleic acid microarray, a method for producing the same, and a base material used therefor.
  • a DNA chip based on the former method is produced by combining photolithography and light irradiation chemical synthesis to synthesize oligonucleotides of about 20 to 25 mer on a glass substrate at a high density (US Patent No. 1). 5 4 4 5 9 3 4 Specification, U.S. Pat.No. 5 7 4
  • a DNA chip by the latter method is typically produced by spotting a pre-prepared DNA fragment on a slide glass at a high density (US Pat. No. 5,880,071).
  • the above-mentioned DNA chip is expensive to manufacture with a glass substrate chip and is expensive.
  • resin-made chips are advantageous in terms of cost, the fixation of DNA to the base material is inferior to that of glass substrates, and the strength of the fixation and the improvement of analysis power have not been resolved.
  • An object of the present invention is to provide a nucleic acid microarray, a base material for a nucleic acid microarray, and the like that can sufficiently fix a nucleic acid without introducing a specific reactive group into a substrate or a nucleic acid and performing a covalent bond. is there.
  • the inventors of the present invention have found that fixing the base material and the DNA is strengthened by applying a specific treatment to the plastic base material, and have completed the present invention.
  • the present invention is as follows.
  • a nucleic acid microarray in which a nucleic acid is immobilized on a plastic substrate, and at least a surface portion of the substrate is provided with an oxide-based filter, a hydroxide-based filter, a carbonate-based filter, and a sulfate.
  • a nucleic acid microarray comprising an inorganic filler selected from the group consisting of a series filler.
  • a nucleic acid microarray in which a nucleic acid is immobilized on a plasma-treated or ion beam-treated plastic substrate, and an oxide-based filter, a hydroxide-based filter, and a carbonate on at least the surface of the substrate.
  • a nucleic acid microarray comprising an inorganic filler selected from the group consisting of a series filler and a sulfate series filler.
  • nucleic acid microarray according to (4) wherein the inorganic filler is titanium dioxide.
  • the plastic is polypropylene, polymethyl methacrylate, polycarbonate, or polyethylene terephthalate.
  • a method for producing a nucleic acid microarray comprising:
  • a base material for nucleic acid microarrays made of plastic comprising an oxide-based filler, a hydroxide-based filter, a carbonate-based filter, and a sulfate-based filter on at least a surface portion of the substrate.
  • a substrate comprising an inorganic filler selected from the group consisting of:
  • nucleic acid microarray according to any one of (1) to (7) or the above (8) to (1 2) a step of contacting a nucleic acid microarray obtained by the production method according to any one of the above and a sample containing the nucleic acid to be analyzed;
  • a method for detecting a nucleic acid having a specific base sequence is a method for detecting a nucleic acid having a specific base sequence.
  • Figure 1 compares the fixability of DNA for polypropylene substrates with and without titanium dioxide.
  • Figure 2 shows a comparison of DNA fixability between a substrate made of polyethylene terephthalate containing titanium dioxide and a substrate not containing it.
  • Figure 3 shows the color development of a DNA microarray using a polycarbonate substrate containing titanium dioxide.
  • the nucleic acid microarray of the present invention is a nucleic acid microarray in which a nucleic acid is immobilized on a plastic substrate, and an oxide-based filler, a hydroxide-based filter, and a carbonate-based filter on at least a surface portion of the substrate. And an inorganic filler selected from the group consisting of sulfate-based fillers.
  • the nucleic acid microarray refers to a nucleic acid (also referred to as a probe) mounted on the surface of a plastic substrate.
  • the resin used for the plastic substrate of the nucleic acid microarray of the present invention include polyolefin resins such as polyethylene, polypropylene, polypentene, polymethylpentene, and saturated cyclic polyolefin; acryl resins such as polymethyl methacrylate; polycarbonate; polyacetal ; Ethylene ⁇ Vinyl alcohol copolymer resin; Polystyrene, AS (acrylonitrile 'styrene) tree Polystyrene resins such as oil, ABS (acrylonitrile butadiene styrene) resin; vinyl chloride resins such as polyvinyl chloride and polyvinylidene chloride; cellulose acetate; polyphenylene ether resin; polyphenylene nord resin; Resin; Polyetheretherketone resin; Thermosetting resin such as phenol resin, urea resin, melamine resin, unsaturated polyester resin, polyimide, epoxy resin, moon; Polyester terephthalate such as polyethylene terephthal
  • polypropylene, polymethylmethacrylate, polycarbonate and polyethylene terephthalate are preferred because they are inexpensive and easily available.
  • biodegradable resins or resin materials that have established recycling methods (eg, polyethylene, polypropylene, polystyrene, polyethylene terephthalate, etc.), but this is not a limitation. Absent.
  • the inorganic filler is a plastic auxiliary material that is generally added to a resin as an extender, and depending on the type, the viscosity increases, the molding compression ratio decreases, the opacity increases, and the light resistance. Effects such as improvement of mechanical properties, improvement of mechanical characteristics, and improvement of appearance may be added. From the viewpoint of easy visual detection of light emission detection in the nucleic acid microarray, those that improve opacity and those that improve the appearance are preferred, but are not limited thereto.
  • the inorganic filler examples include spherical particles, fibers, and flakes, and spherical particles are preferable from the viewpoint of dispersibility of the inorganic filler in the resin.
  • the average particle diameter of the spherical particles is preferably from 0.2 to 5.0 O / zm, more preferably from 0.5 to 2.0 m, from the viewpoint of dispersibility of the inorganic filler in the resin.
  • the average particle size of the inorganic filler is a value measured by a light scattering particle size distribution measuring device.
  • the inorganic filler in the present invention is selected from the group consisting of oxide fillers, hydroxide fillers, carbonate fillers, and sulfate fillers.
  • oxide fillers include titanium dioxide, silica, diatomaceous earth, alumina, iron oxide, zinc oxide, magnesium oxide, etc .; hydroxide fillers such as aluminum hydroxide, magnesium hydroxide, etc .; carbonates
  • examples of the filler include calcium carbonate, magnesium carbonate, and dolomite
  • examples of the sulfate-based filler include barium sulfate, calcium sulfate, and ammonium sulfate.
  • the inorganic filler may be used singly or in combination of two or more.
  • the inorganic filler described above can impart a positive charge, which is considered to be advantageous for immobilization of nucleic acids, to the substrate surface. Furthermore, an oxide-based filler is preferable, and titanium dioxide, which is excellent as a pigment, is more preferable.
  • the blending amount of the inorganic filler is appropriately set according to the type of the resin and the inorganic filler in which the inorganic filler is blended, but from the viewpoint of maintaining the shape of the base material satisfactorily with respect to 100 parts by weight of the resin.
  • the inorganic filler is 20 parts by weight or less, preferably 10 parts by weight or less.
  • the hydrophobicity in the present invention refers to a property having a contact angle 0 with water described later of about 65 ° or more. Furthermore, if the hydrophobic plastic is subjected to a surface treatment described later, the wettability with respect to an aqueous solution in which nucleic acid fragments are dissolved or dispersed in an aqueous medium is improved, so that the nucleic acid can be sufficiently fixed. Become.
  • the inorganic filler should just be contained in the surface part of the said base material at least. Therefore, the inorganic filler may be contained in the entire base material, or may be unevenly distributed on the surface portion, the unevenly distributed portion may be the entire surface portion, and the surface portion on which the nucleic acid is immobilized. It may be a partial region.
  • a base material containing an inorganic filler is formed on the whole base material formed by molding a plastic containing an inorganic filler; a plastic molded plate not containing an inorganic filler contains an inorganic filler.
  • examples include, but are not limited to, a multi-layer substrate in which plastic molded plates are laminated. When laminating plastic molded plates containing inorganic filler, it is recommended to fix nucleic acids. You may laminate
  • the substrate can be produced according to a known method.
  • resin and inorganic fillers and other additives as necessary are mixed and kneaded with a mixer, Henschel, extruder, kneader or roll, etc., and molded by extrusion molding, injection molding, compression molding or calendar molding, etc. can do.
  • a mixer Henschel, extruder, kneader or roll, etc.
  • molded by extrusion molding, injection molding, compression molding or calendar molding, etc. can do.
  • the base material can be produced by cutting into an appropriate size if necessary.
  • the plastic substrate is a polypropylene substrate
  • about 10 parts by weight of titanium dioxide fine particles are mixed with 100 parts by weight of a polypropylene resin, and are formed into a substrate by coextrusion. A method, but not limited to this.
  • the size of the substrate can be appropriately determined according to the purpose of use of the microarray, but from the viewpoint of ease of handling at the bedside, it is about 1 to 100 mm 2 , preferably about 1 0: L 0 0 O mm 2
  • the plastic substrate is preferably subjected to a surface treatment if necessary.
  • a surface treatment By this surface treatment, an appropriate surface roughness of the substrate surface can be obtained, wettability to an aqueous solution in which nucleic acid fragments are dissolved or dispersed in an aqueous medium is improved, and nucleic acid can be sufficiently fixed. Become.
  • Examples of the surface treatment method include ion beam treatment or plasma treatment, preferably ion beam treatment using an inert gas as an ionization gas or plasma treatment in an inert gas atmosphere.
  • the ion beam treatment refers to ion implantation and film formation by the energy generated by ionizing inert gas, irradiating the surface of the plastic substrate with high-speed acceleration by applying voltage, and colliding with it.
  • a surface treatment method that imparts the effect of improving etching and wettability.
  • the nucleus after the ion beam processing is used.
  • nitrogen gas and argon gas are preferred.
  • nitrogen can be more firmly fixed by improving the wettability of the surface of the plastic substrate and ion charging of the surface. Gas is more preferred.
  • the method of ion beam processing is not particularly limited.
  • a device equipped with an ECR ion gun that uses cyclotron resonance (ECR) of electrons in a magnetic field under reduced pressure can be irradiated with an acceleration energy of about 300 to 700 V at a dose of about 1.0 X 10 ° 2 ozZcm 2 .
  • ECR cyclotron resonance
  • Examples of the apparatus used include, but are not limited to, a small ECR ion shower apparatus (EIS-200 ER) manufactured by Erio Nitas.
  • the number of such treatments is not particularly limited as long as desired wettability and surface roughness are obtained, but from the viewpoint of suppressing wettability deterioration, 0.25 to 2.0 X 10 20 io nZc per time.
  • the dose of m 2 is preferably irradiated at least 5 times or more, preferably 10 times or more, but is not limited thereto.
  • the plasma treatment is performed by irradiating a solid surface with plasma generated by the ionizing action of the inert gas by discharging in an inert gas atmosphere, etching the surface, improving wettability, and introducing functional groups.
  • the discharge include corona discharge (high-pressure and low-temperature plasma), arc discharge (high-pressure and high-temperature plasma), and glow discharge (low-pressure and low-temperature plasma). Of these, corona discharge is preferred from the viewpoint of surface treatment reactivity. However, it is not limited to this.
  • the inert gas in the plasma treatment include nitrogen gas, argon gas, oxygen gas, helium gas, neon gas, and xenon gas.
  • nitrogen gas and argon Gas is preferred.
  • DNA or RNA having a phosphate skeleton which is a polyanion
  • an amine group and / or an amino group are generated on the surface of the plastic substrate, thereby improving the wettability of the surface and ions on the surface.
  • yo Nitrogen gas is more preferable because it can be fixed more firmly.
  • the plasma treatment method is not particularly limited.
  • the base material is placed in a sealed container, and a nitrogen gas atmosphere (about 10 to about 50 to about 50 to 50 ° C.) is used. Under 20 Pa), discharge at an output of about 100-50 OW and process for about 100-1 000 seconds.
  • the apparatus used include, but are not limited to, a small high-performance plasma surface treatment apparatus (PDC 200 series) manufactured by Yamato Scientific.
  • the number of such treatments is not particularly limited as long as desired wettability and surface roughness are obtained, but is usually about 1 to 10 times.
  • the wettability of the surface of the plastic substrate is increased.
  • the wettability can be determined by measuring the contact angle ⁇ between the plastic substrate and water.
  • the contact angle 0 of water after the treatment is 60 ° or less, preferably 40 ° or less, particularly preferably 20 ° or less, from the viewpoint of nucleic acid fixation strength.
  • the water contact angle ⁇ on the surface of the base material before treatment is, for example, about 80 ° for polymethyl metatalylate and about 76 ° for polycarbonate.
  • the contact angle 0 is a value measured with an optical microscope after 0.25 ⁇ L of distilled water was dropped.
  • the surface roughness R a (JISB 060 1-1 9 94) of the plastic substrate is preferably from 0.06 to 0.5 zm from the viewpoint of making nucleic acid fixation stronger, and from 0.08 to 0. 45 ⁇ m is preferred.
  • the surface roughness Ra is a value measured with a laser microscope.
  • a nucleic acid microarray can be produced by immobilizing nucleic acids on the substrate obtained as described above.
  • the nucleic acid (also referred to as a probe) in the present invention refers to DNA, RNA, PNA or a derivative thereof.
  • the nucleic acid (probe) may be naturally derived, artificially synthesized, single stranded or double stranded.
  • the DNA may be natural or synthetic DNA, cDNA reverse-transcribed from mRNA, etc. It is not particularly limited.
  • the RNA is not particularly limited, such as mRNA, cRNA or rRNA.
  • PNA refers to a molecule having a nucleobase in the peptide backbone.
  • the derivative means a product obtained by appropriately modifying the DNA, RNA, or PNA within the scope of the object of the present invention.
  • DNA RNA
  • PNA single-stranded DNA is preferable in terms of production cost, the point that various enzymes can be used, and a wide range of applications, but is not limited thereto.
  • Examples of the scope of application include prediction of drug sensitivity of individual patients, determination of pathogenic bacteria or resistance, and determination of individual constitution, and generally refers to applications in a field called tailor-made medicine. However, it is not limited to this.
  • the nucleic acid microarray of the present invention is generally called a DNA chip when the nucleic acid (probe) is a single-stranded DNA.
  • the type of nucleic acid (probe) mounted on the nucleic acid microarray of the present invention can be appropriately set according to the purpose of use. For example, when it is used to predict individual drug susceptibility, a single nucleotide polymorphism (SNP) is generally detected, so the number of polymorphisms at each polymorphic site to be detected is detected. Is the sum of More specifically, when predicting the susceptibility of the osteoporosis therapeutic agent disclosed in Japanese Patent Application Laid-Open No.
  • a nucleic acid having an arbitrary base sequence may be mounted as a control.
  • the length of the nucleic acid (probe) in the present invention is at least 50 bases as long as it can be easily immobilized on a plastic substrate by UV irradiation and can hybridize with the nucleic acid to be measured. That's fine.
  • it is 50 to 500 bases, preferably about 200 to 40 bases.
  • nucleic acid to be immobilized in the case of a nucleic acid derived from nature, a nucleic acid prepared by isolation and purification by a known method and cleaving to a predetermined length with an enzyme or the like can be used if necessary.
  • a synthetic nucleic acid those prepared by a known synthesis method can be used depending on the type of nucleic acid.
  • DNA those prepared by reverse transcription reaction or polymerase chain reaction can be suitably used.
  • the length of the base sequence necessary for detection is generally about 10 to 30 bases.
  • the above-mentioned length of 50 bases or more can be achieved by adding a sequence that does not affect the detection to the end of the nucleic acid sequence prepared as described above.
  • an oligomer selected from the group consisting of poly dT, poly d A, poly d C and poly d G can be added.
  • poly d T oligomer can be added. It is preferable to add it.
  • the poly dT oligomer can be added by terminal transferase or the like, but is not limited thereto.
  • the nucleic acid is immobilized by preparing a solution of the nucleic acid, spotting the solution on the surface of the plastic substrate, preferably the surface of the plastic substrate after the ion beam treatment or plasma treatment, and irradiating with UV. .
  • an aqueous solvent such as a phosphate buffer is generally used.
  • the spotting method is not particularly limited, and examples thereof include a method using a dispenser (such as SMP-3 manufactured by Musashi Engineering Co., Ltd.).
  • a plastic substrate containing an inorganic filler at least on the surface portion preferably after the substrate is subjected to ion beam treatment or plasma treatment.
  • Oxide filler, hydroxide filler, carbonate filler and sulfate The inorganic filler selected from the fillers imparts a positive charge to the substrate surface, which is considered to favor the immobilization of nucleic acids, more preferably
  • the surface shape suitable for nucleic acid fixation can be produced.
  • the nucleic acid can be easily fixed.
  • UV irradiation UV having a wavelength of about 250 to 350 nm is usually used, and irradiation is performed for about 1 to 10 minutes with about 5000 to 8 000 ⁇ wZcm 2 , but is not limited thereto.
  • washing or prokking treatment may be performed from the viewpoint of reducing nonspecific adsorption.
  • the nucleic acid microarray of the present invention thus obtained can be suitably used for the following detection method of the present invention.
  • the nucleic acid microarray of the present invention can be used in a method for detecting a nucleic acid having a specific base sequence.
  • the detection method includes a step of bringing the microarray into contact with a sample containing a nucleic acid to be analyzed, and a step of detecting a nucleic acid hybrid formed by the contact step.
  • the nucleic acid (target) to be analyzed a DNA fragment sample or RNA fragment sample whose sequence or function is unknown can be used.
  • the target nucleic acid can be isolated from a living cell or tissue sample for the purpose of examining gene expression.
  • the target nucleic acid is mRNA, it is preferably converted to cDNA by reverse transcription.
  • the target nucleic acid is preferably amplified by a reaction system containing a labeled primer or labeled dNTP, but is not limited thereto.
  • the method for amplifying the target nucleic acid is not particularly limited, such as PCR method, LAMP method, and Invader method, and can be amplified using reagents and equipment suitable for each method.
  • Non-RI methods include fluorescent labeling and enzyme labeling. Any fluorescent label can be used as long as it can bind to the base part of the nucleic acid, such as cyan dyes (eg, Cy 3 and Cy 5 in the Cy Dye TM series), rhodamine 6 G reagent. , N-acetoxy_N 2 —acetylyl nofnoleolene (AAF), AA IF (AAF's iodine derivative), and the like are not limited thereto.
  • cyan dyes eg, Cy 3 and Cy 5 in the Cy Dye TM series
  • rhodamine 6 G reagent e.g, N-acetoxy_N 2 —acetylyl nofnoleolene (AAF), AA IF (AAF's iodine derivative), and the like are not limited thereto.
  • enzyme labels include, but are not limited to, alkaline phosphatase, peroxy, and nandase.
  • the hybridization can be carried out by spotting a target nucleic acid, preferably an aqueous solution in which a labeled target nucleic acid is dissolved or dispersed, onto the nucleic acid microarray of the present invention.
  • the amount of spotting is preferably in the range of 1 to 100 ⁇ L from the viewpoint of facilitating detection visually or with an apparatus, but is not limited thereto.
  • Hybridization may be performed under conditions that allow the target nucleic acid and the nucleic acid immobilized on the array to form a hybrid. Usually, it is preferably carried out in a temperature range of about 25 to 70 ° C. and in a range of about 10 minutes to 24 hours, but is not limited thereto.
  • wash with washing solution to remove unreacted target nucleic acid. Examples of the washing solution include those containing a surfactant in a buffer solution.
  • a step of detecting the nucleic acid hybrid formed by the contacting step The detection method can be appropriately set according to the label.
  • RI labeling it can be detected by autoradiography.
  • fluorescent labels light with an excitation wavelength suitable for each fluorescent label is irradiated and the fluorescence intensity is measured. Can be detected.
  • enzyme labeling measurement can be performed by adding a substrate for each enzyme.
  • alkaline phosphatase for example, p-nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolinolephosphate p-toluidine salt (BC IP) are added as substrates.
  • NBT p-nitroblue tetrazolium
  • BC IP 5-bromo-4-chloro-3-indolinolephosphate p-toluidine salt
  • the detection method based on the combination of the Al force phosphatase label and the substrate NB TZB C IP can be suitably used for clinical diagnosis because the measurement result can be visually observed.
  • the nucleic acid microarray of the present invention can be used for various applications such as gene expression monitoring, dienotyping, and genetic polymorphism screening. In clinical practice, it is expected to be applied to clinical diagnosis and tailor-made medicine.
  • a PP substrate containing an inorganic filler was prepared by a co-extrusion machine using 500 g of polypropylene (PP) as a resin and 50 g of titanium dioxide particles having an average particle diameter of about 500 ⁇ as an inorganic filler.
  • PP polypropylene
  • EI S-200 ER manufactured by Erio Nitas
  • EI S-200 ER manufactured by Erio Nitas
  • DNA probe As the DNA probe, the DNA probe shown in SEQ ID NOS: 1 and 2 (provided by Sigmajienosis Japan) was used.
  • the DNA probe of SEQ ID NO: 1 is an estrogen receptor allele (X ba I polymorphism) that is cleaved by the restriction enzyme X ba I in the intron region between the first and second etasons. (X-type) can be detected.
  • the DNA probe of SEQ ID NO: 2 can detect a sequence (X type) that is not cleaved by the restriction enzyme X ba I among the estrogen receptor alleles (X ba I polymorphism).
  • Polythymine was added to these DNA probes using terminal transferase (manufactured by New England Bio 1ab) at the 3 and terminal ends. Specifically, 41 1 for terminal transferase (SO unit Z zl), 10 xl for deoxythymidine triphosphate (10 pmol Z / l), DNA probes of SEQ ID NOS: 1 and 2 (5 O mM) ) 4 ⁇ 1, 5 ⁇ 1 of NEB uffer 4 attached to the product, and 50 ⁇ 1 of purified water containing 5 ⁇ 1 of the force codylate buffer supplied with the product. By adding 20 XSSC buffer 50 / i 1 attached to the product, a polythymine-added nucleic acid probe (average length of about 400 bp) 2 pmol / ⁇ 1 was obtained.
  • terminal transferase manufactured by New England Bio 1ab
  • X-type detection probe (SEQ ID NO: 1): tctggagttg ggatga
  • x-type detection probe (SEQ ID NO: 2): gtggtctaga gttggg
  • Nucleic acid microarrays were produced by immobilizing 2 nm UV light for 2 minutes.
  • Example 1 a DNA microarray was produced in the same manner as in Example 1 except that no inorganic filler was contained.
  • Experimental example 1 Inspection using DNA microarray 1
  • the nucleotide sequence containing the XbaI polymorphism was amplified by the PCR method using Taq DNA polymerase (Roche Diagnostats). In the amplification reaction, the denaturation process was 94 ° C for 30 seconds, the annealing process was 55 ° C for 20 seconds, the chain extension process was 72 ° C for 20 seconds, and 30 cycles for one cycle.
  • Reno primer (Care [
  • Example 1 To 20 ⁇ L of the amplified DNA solution, add a solution (20 ⁇ L) of sodium hydroxide (5 ⁇ ) and ethylenediamine tetraacetic acid (0.05 ⁇ ), stir well, and let stand for 5 minutes. It was denatured into a main chain. Solution containing denatured DNA, solution containing sodium dodecyl sulfate (0.01 w_v%), sodium chloride (1.8 w / v%) and sodium citrate (1. OwZv%) (l mL) In addition, one microarray of Example 1 or Comparative Example 1 was infiltrated and shaken at a reaction temperature of 45 ° C. for 30 minutes for hybridization.
  • sodium hydroxide 5 ⁇
  • ethylenediamine tetraacetic acid 0.05 ⁇
  • alkaline phosphatase-labeled streptavidin add alkaline phosphatase-labeled streptavidin, and then add p-nitroblue tetrazolium (NBT) and 5-promo-4-chloro-3-indolyl phosphate ⁇ -toluidine salt (BCIP).
  • NBT p-nitroblue tetrazolium
  • BCIP 5-promo-4-chloro-3-indolyl phosphate ⁇ -toluidine salt
  • Figure 1 shows the result of color development.
  • the DNA microarray prepared from the PP substrate containing titanium dioxide of Example 1 can be easily judged visually, whereas Comparative Example 1 DNA microarrays made from PP substrates that did not contain any titanium dioxide produced almost no color. This indicates that inclusion of an inorganic filler in the plastic substrate can efficiently fix the nucleic acid to the plastic substrate.
  • Example 2
  • a DNA microarray was produced in the same manner as in Example 1 except that a polyethylene terephthalate (PET) substrate was used instead of the polypropylene substrate in Example 1.
  • PET polyethylene terephthalate
  • Example 2 a DNA microarray was produced in the same manner as in Example 2 except that no inorganic filler was contained.
  • Figure 2 shows the results of color development.
  • the DNA microarray prepared from the PET substrate containing the inorganic filler of Example 2 can be easily judged visually, while the comparative example
  • the DNA microarray made from the PET substrate that does not contain 2 inorganic fillers hardly developed color.
  • a DNA microarray was produced in the same manner as in Example 1 except that a polycarbonate (PC) substrate was used instead of the PP substrate in Example 1.
  • Figure 3 shows the color development.
  • Samples for surface roughness measurement and X-ray photoelectron spectroscopy (XP S) were prepared. Specifically, in Example 3, the substrate itself was used without immobilizing the nucleic acid.
  • the surface roughness Ra was measured using a laser microscope (manufactured by Keyence Corporation). Specifically, the average surface roughness in the observation field was measured using the analysis software attached to the product. As a result, it was about 0.0 before the ion beam irradiation, but about
  • Samples for X-ray photoelectron spectroscopy were prepared. Specifically, a nucleic acid microarray substrate was produced in the same manner as in Example 4 except that in Example 4, the number of ion beam irradiations was set to 2. In this example, since the purpose is to prepare a sample for X-ray photoelectron spectroscopy (XPS), no nucleic acid is immobilized. The ion irradiation interval was set to 30 seconds.
  • Example 5 a nucleic acid microarray substrate was produced in the same manner as in Example 5 except that the number of ion beam irradiations was three.
  • Example 5 a nucleic acid microarray substrate was produced in the same manner as in Example 5 except that the number of ion beam irradiations was changed to 4.
  • Example 4 a nucleic acid microarray substrate was produced in the same manner as in Example 4 except that the substrate did not contain an inorganic filler.
  • Example 4 Surface analysis of a DNA microarray substrate
  • the elemental composition ratios on the polycarbonate substrate surfaces of Examples 4 to 7 and Comparative Example 4 were measured using an X-ray photoelectron spectrometer (XPS, ULVAC-FAI). Specifically, A 1 ⁇ ⁇ ⁇ ; line was used as the X-ray source, and measurement was performed using a charged neutralization gun at approximately 25 ° C and under reduced pressure (approximately 10 to 15 Pa or less) (analysis area: Diameter 8 0 0 / m). The results are shown in Table 1. Since titanium was confirmed in the region 5 nm deep from the surface, it was confirmed that titanium dioxide was contained in at least the surface portion of the polycarbonate substrate. In addition, by increasing the number of ion beam irradiation, It was confirmed that the composition ratio of titanium increased. This is considered to be the reason why the nucleic acid is more immobilized by increasing the number of ion beam irradiations.
  • XPS X-ray photoelectron spectrometer
  • a nucleic acid microarray and a substrate for nucleic acid microarray can be provided at low cost. Further, the base material can fix the nucleic acid so as to be strong and suitable for hybridization. According to the method for producing a nucleic acid microarray of the present invention, the nucleic acid microarray can be produced inexpensively and efficiently. According to the detection method using the nucleic acid microarray of the present invention, DNA expression analysis and genotyping can be performed at low cost and with high sensitivity, compared with the conventional method. In addition, according to the detection method of the present invention, by introducing a specific label into the nucleic acid hybrid, nucleic acid can be detected and determined with a so-called bedside without using a large-scale detection apparatus.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L’invention concerne une micromatrice d’acide nucléique qui peut immobiliser sur celle-ci un acide nucléique de façon satisfaisante sans avoir besoin de l’immobiliser par l’intermédiaire d’une liaison covalente fournie au moyen de l’introduction d’un groupe réactif spécifique à un substrat ou à l’acide nucléique; un substrat pour la micromatrice d’acide nucléique ; et autres. L'invention concerne une micromatrice d’acide nucléique comprenant un substrat plastique et un acide nucléique immobilisé sur le substrat, au moins la surface du substrat contenant une charge inorganique choisie parmi le groupe composé d’une charge oxyde, d’une charge hydroxyde, d’une charge carbonate, et d’une charge sulfate ; une micromatrice d’acide nucléique comprenant un substrat plastique qui a été traité avec un plasma ou un faisceau d’ions et un acide nucléique immobilisé sur le substrat, ladite au moins la surface du substrat contenant une charge inorganique choisie parmi le groupe composé d’une charge oxyde, d’une charge hydroxyde, d’une charge carbonate et d’une charge sulfate ; un traitement pour la production de la micromatrice d’acide nucléique ; un substrat pour la micromatrice d’acide nucléique ; et un procédé pour la détection d’un acide nucléique en utilisant la micromatrice d’acide nucléique.
PCT/JP2006/307284 2005-03-31 2006-03-30 Micromatrice d’acide nucleique, traitement pour sa production, et substrat pour une micromatrice d’acide nucleique Ceased WO2006104260A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007510586A JP5238250B2 (ja) 2005-03-31 2006-03-30 核酸マイクロアレイ、その製造方法および核酸マイクロアレイ用基材

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005105392 2005-03-31
JP2005-105392 2005-03-31

Publications (1)

Publication Number Publication Date
WO2006104260A1 true WO2006104260A1 (fr) 2006-10-05

Family

ID=37053505

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/307284 Ceased WO2006104260A1 (fr) 2005-03-31 2006-03-30 Micromatrice d’acide nucleique, traitement pour sa production, et substrat pour une micromatrice d’acide nucleique

Country Status (2)

Country Link
JP (1) JP5238250B2 (fr)
WO (1) WO2006104260A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015045567A (ja) * 2013-08-28 2015-03-12 コニカミノルタ株式会社 分析チップ
US9168532B2 (en) 2013-01-24 2015-10-27 Sabic Global Technologies B.V. Microwell plate
US9180456B2 (en) 2013-01-24 2015-11-10 Sabic Global Technologies B.V. Microwell plate
US9186674B2 (en) 2013-01-24 2015-11-17 Sabic Global Technologies B.V. Polycarbonate microfluidic articles
CN109652295A (zh) * 2014-01-31 2019-04-19 凸版印刷株式会社 生物分子分析试剂盒及生物分子分析方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003279574A (ja) * 2002-03-27 2003-10-02 Sumitomo Bakelite Co Ltd マイクロチップ用基板及びマイクロチップ
JP2004108859A (ja) * 2002-09-17 2004-04-08 Fuji Photo Film Co Ltd 生化学解析用ユニット
JP2005030913A (ja) * 2003-07-14 2005-02-03 Sumitomo Bakelite Co Ltd バイオチップ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE173508T1 (de) * 1988-05-20 1998-12-15 Hoffmann La Roche Befestigung von sequenzspezifischen proben
JP3806022B2 (ja) * 2001-10-30 2006-08-09 住友ベークライト株式会社 マイクロチップ用基板
JP2004061205A (ja) * 2002-07-26 2004-02-26 Sony Corp 検出表面及びセンサーチップ

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003279574A (ja) * 2002-03-27 2003-10-02 Sumitomo Bakelite Co Ltd マイクロチップ用基板及びマイクロチップ
JP2004108859A (ja) * 2002-09-17 2004-04-08 Fuji Photo Film Co Ltd 生化学解析用ユニット
JP2005030913A (ja) * 2003-07-14 2005-02-03 Sumitomo Bakelite Co Ltd バイオチップ

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9168532B2 (en) 2013-01-24 2015-10-27 Sabic Global Technologies B.V. Microwell plate
US9180456B2 (en) 2013-01-24 2015-11-10 Sabic Global Technologies B.V. Microwell plate
US9186674B2 (en) 2013-01-24 2015-11-17 Sabic Global Technologies B.V. Polycarbonate microfluidic articles
JP2015045567A (ja) * 2013-08-28 2015-03-12 コニカミノルタ株式会社 分析チップ
CN109652295A (zh) * 2014-01-31 2019-04-19 凸版印刷株式会社 生物分子分析试剂盒及生物分子分析方法

Also Published As

Publication number Publication date
JPWO2006104260A1 (ja) 2008-09-11
JP5238250B2 (ja) 2013-07-17

Similar Documents

Publication Publication Date Title
US20060073501A1 (en) Methods for long-range sequence analysis of nucleic acids
CN1189573C (zh) 多核苷酸序列变异的微阵列型分析
EP2535429A1 (fr) Procédés et systèmes d'enrichissement de séquences à base de solution et d'analyse de régions génomiques
JP2009171969A (ja) マイクロアレイハイブリダイゼーションアッセイ方法
CN1390264A (zh) 长寡核苷酸阵列
JP2007502116A (ja) 核酸サンプルを調製するための方法およびキット
US20020048760A1 (en) Use of mismatch cleavage to detect complementary probes
CA2350756A1 (fr) Procedes et appareil pour hybridation en continu
CA2298017A1 (fr) Fonctionnalites multiples a l'interieur d'un element matriciel et utilisations en decoulant
JP5238250B2 (ja) 核酸マイクロアレイ、その製造方法および核酸マイクロアレイ用基材
US20110195862A1 (en) Devices, methods and systems for target detection
JP4772211B2 (ja) Ｄｎａチップの製造方法
JP4691383B2 (ja) 核酸マイクロアレイおよびその製造方法
Arlinghaus et al. Development of PNA microarrays for gene diagnostics with TOF-SIMS
JP2006282871A (ja) 疎水性高分子基板表面の親水性維持方法
WO2006062009A1 (fr) Procede d’elongation de la chaine d’adn, procede d’amplification de la chaine d’adn et puce a adn pour elongation de la chaine d’adn
JP4419715B2 (ja) バイオチップ用基板およびバイオチップ
JP5043320B2 (ja) メチル化ｄｎａ及び／又は非メチル化ｄｎａの検出方法
JP4256789B2 (ja) 静電層を有する固体支持体及びその用途
JP2004024203A (ja) 飛行時間型二次イオン質量分析法によるｒｎａの分析方法
JP4916689B2 (ja) Ｄｎａ鎖増幅方法
JP2003212974A (ja) 高分子薄膜、高分子薄膜の製造方法、およびバイオチップ
Cho et al. Fragmentation of surface adsorbed and aligned DNA molecules using soft lithography for Next-Generation Sequencing
Consolandi et al. Development of oligonucleotide arrays to detect mutations and polymorphisms
JP2005055365A (ja) 核酸分子を固定化するための固体支持体

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007510586

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06731232

Country of ref document: EP

Kind code of ref document: A1